On Sep 16, 2021 Rhaeos closed a Grant round and raised $4,000,000 from National Institute of Neurological Disorders and Stroke, featuring lead investors National Institute […]
Series B – Amolyt Pharma
On Sep 16, 2021 Amolyt Pharma closed a Series B round and raised $80,000,000 from Andera Partners, ATEM Capital, Bpifrance, Credit Agricole Entreprises, Eurazeo, Kurma […]
Series B – Othram
On Sep 16, 2021 Othram closed a Series B round and raised $18,000,000 from Gigafund, featuring lead investors Gigafund. About the company: Othram is located […]
Series C – IASO Biotherapeutics
On Sep 16, 2021 IASO Biotherapeutics closed a Series C round and raised $108,000,000 from CCB International, CDH Investments, CNCB Capital, Co-Stone Venture Capital, Everbright, […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Grant – Rhaeos
On Sep 16, 2021 Rhaeos closed a Grant round and raised $4,000,000 from National Institute of Neurological Disorders and Stroke, featuring lead investors National Institute […]
Series B – Amolyt Pharma
On Sep 16, 2021 Amolyt Pharma closed a Series B round and raised $80,000,000 from Andera Partners, ATEM Capital, Bpifrance, Credit Agricole Entreprises, Eurazeo, Kurma […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Agena Bioscience acquired by Mesa Laboratories
Sep 14, 2021 Mesa Laboratories has entered into an agreement to acquire Agena Bioscience in a $300,000,000 deal. Mesa Laboratories based at Lakewood, Colorado, United […]
Series B – Vanqua Bio
On Sep 14, 2021 Vanqua Bio closed a Series B round and raised $85,000,000 from Avoro Ventures, Eli Lilly, Omega Funds, OrbiMed, OUP (Osage University […]